FunPep

Announcement of Fund Raising through Third Party Allocation of New Shares

Announcing Acceptance into AMED Grant Program

Submission of a Phase II Clinical Trial Plan for Functional Peptide SR-0379

Announcing Acceptance into the AMED Grant Program

Announce of Conclusion of Option Agreement with Sumitomo Dainippon Pharma